4.4 Article

Vivax malaria in Duffy-negative patients shows invariably low asexual parasitaemia: implication towards malaria control in Ethiopia

Journal

MALARIA JOURNAL
Volume 21, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12936-022-04250-2

Keywords

Duffy antigen; Polymorphism; Asexual parasitaemia; Ethiopia

Funding

  1. Bill and Melinda Gates Foundation [INV-015996]
  2. European and Developing Countries Clinical Trials Partnership (EDCTP)
  3. Malaria Genetics and Resistance Unit, Department of Parasites and Insect Vectors of Pasteur Institute, Paris, France
  4. Bill and Melinda Gates Foundation [INV-015996] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

This study aimed to determine the distribution of P. vivax asexual parasitaemia according to Duffy antigen polymorphisms in Ethiopia. The results showed that P. vivax parasitaemia was significantly lower in Duffy-negative patients, suggesting a less efficient invasion of Duffy-negative reticulocytes by P. vivax. Additionally, the low parasitaemia observed in Duffy-negative individuals could serve as an undetected reservoir, potentially delaying the elimination of vivax malaria in Ethiopia.
Background The increase in detections of Plasmodium vivax infection in Duffy-negative individuals in Africa has challenged the dogma establishing the unique P. vivax Duffy Binding Protein-Duffy antigen receptor for chemokines (PvDBP-DARC) pathway used by P. vivax merozoites to invade reticulocytes. Information on the impact of Duffy antigen polymorphisms on the epidemiology of P. vivax malaria remains elusive. The objective of this study was to determine the distribution of asexual parasitaemia of P. vivax according to the Duffy antigen polymorphisms in Ethiopia. Methods DNA was extracted from dried blood spots (DBS) collected from prospectively recruited 138 P. vivax-infected patients from health centres. The identification and estimation of P. vivax asexual parasitaemia were performed by microscopic examination and quantitative real-time polymerase chain reaction (PCR). Duffy genotyping was conducted by DNA sequencing in a total of 138 P.vivax infected samples. Results The proportion of Duffy-negatives (FY*B-ES/FY*B-ES) in P. vivax infected patients was 2.9% (4/138). Duffy genotype FY*B/FY*B-ES (48.6%) was the most common, followed by FY*A/FY*B-ES genotype (25.4%). In one patient, the FY*02 W.01/FY*02 N.01 genotype conferring a weak expression of the Fy(b) antigen was observed. All P.vivax infected Duffy-negative patients showed low asexual parasitaemia (<= 110 parasites/mu L). The median P. vivax parasitaemia in Duffy-negative patients (53 parasites/mu L) was significantly lower than those found in homozygous and heterozygous individuals (P < 0.0001). Conclusion Plasmodium vivax in Duffy-negative patients shows invariably low asexual parasitaemia. This finding suggests that the pathway used by P. vivax to invade Duffy-negative reticulocytes is much less efficient than that used in Duffy-positives. Moreover, the low asexual parasitaemia observed in Duffy-negative individuals could constitute an 'undetected silent reservoir', thus likely delaying the elimination of vivax malaria in Ethiopia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available